Clinical Trials Directory

445 clinical trials found.
Primary Brain and Spinal Cord Tumors

We are doing this study to find out the practicality of using a new program called ViSPad on an electronic tablet. We want to know if this program can help reduce anxiety for cancer patients who are having imaging scans done (for example, MRI).

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital
Primary Brain and Spinal Cord Tumors

We are doing this study to find out if an experimental drug combination of vorasidenib and temozolomide (the study drugs) is a safe and effective option for people who have glioma with IDH1 or IDH2 mutations.

Compensation: No
Ages: 12-110
Oncology
Duke University Hospital
Heart and Circulation

We are doing this study is to see if we can predict carotid artery function using wearable technology (for example, a FitBit®).

Compensation: No
Ages: 18-110
Non-Oncology
Duke University Hospital
Injuries and Wounds

We are doing this study to develop an algorithm to help make accurate decisions about how to manage traumatic wounds. We hope this tool will help us determine the ideal time to use surgery to close major wounds in a way that will best promote healing.

Compensation: No
Ages: 18-70
Non-Oncology
Duke University Hospital
Breast Cancer

We are doing this study to find out if an experimental drug and device system called X-PACT is a safe and effective treatment for various forms of cancer.

Compensation: Yes
Ages: 8-110
Oncology
Duke University Hospital, Other
Genitourinary Cancer

We are doing this study to find out if an experimental drug called XmAb819 (the study drug) is a safe and effective treatment for clear cell renal cell carcinoma (ccRCC).

Compensation: No
Oncology
Lungs and Breathing

We are doing this study to learn how to get the best quality images of lungs in an MRI scanner as people breathe in Xenon gas. We hope this imaging will show key differences between diseased and healthy lungs.

Compensation: Yes
Ages: 18-90
Non-Oncology
Duke University Hospital
Gastrointestinal Cancer

We are doing this study to compare the performance of 2 drugs: zanzalintinib and everolimus. We want to know which option is the most effective for treating neuroendocrine tumors.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital